Literature DB >> 6893598

Anti-actin antibodies revealed by counter-immunoelectrophoresis. Relation to smooth muscle antibodies and bile canalicular antibodies.

H Diederichsen, K Riisom.   

Abstract

In investigations by counter-immunoelectrophoresis, anti-actin antibodies were found in 59% of patients with chronic hepatitis and in 8% of patients with non-hepatic diseases and normal blood donors. Anti-actin antibodies were found more frequently in patients with hepatitis and IgG smooth muscle antibodies than in other groups of diseases and normal subjects with IgG smooth muscle antibodies. Anti-actin antibodies showed no correlation with bile canalicular antibodies.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6893598      PMCID: PMC1146250          DOI: 10.1136/jcp.33.9.876

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  19 in total

1.  Criteria for the classification of systemic lupus erythematosus--status 1972.

Authors:  A S Cohen; J J Canoso
Journal:  Arthritis Rheum       Date:  1972 Sep-Oct

2.  Immunofluorescent and enzymatic staining of bile canaliculi in the same sections of the liver.

Authors:  P M Nielsen; H Diederichsen; N C Linde
Journal:  Am J Clin Pathol       Date:  1972-08       Impact factor: 2.493

3.  Hetero-antibody against bile canaliculi in patients with chronic, clinically active hepatitis.

Authors:  H Diederichsen
Journal:  Acta Med Scand       Date:  1969-10

4.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  K Weber; M Osborn
Journal:  J Biol Chem       Date:  1969-08-25       Impact factor: 5.157

5.  Antibody to smooth muscle in patients with liver disease.

Authors:  G D Johnson; E J Holborow; L E Glynn
Journal:  Lancet       Date:  1965-10-30       Impact factor: 79.321

6.  Rapid detection of Australia antigen by counterimmunoelectrophoresis.

Authors:  D J Gocke; C Howe
Journal:  J Immunol       Date:  1970-04       Impact factor: 5.422

7.  Smooth muscle antibody in malignant disease.

Authors:  J M Whitehouse; E J Holborow
Journal:  Br Med J       Date:  1971-11-27

8.  Studies on the isolation and molecular properties of homogeneous globular actin. Evidence for a single polypeptide chain structure.

Authors:  M K Rees; M Young
Journal:  J Biol Chem       Date:  1967-10-10       Impact factor: 5.157

9.  Human smooth muscle autoantibody. Its identification as antiactin antibody and a study of its binding to "nonmuscular" cells.

Authors:  G Gabbiani; G B Ryan; J P Lamelin; P Vassalli; G Majno; C A Bouvier; A Cruchaud; E F Lüscher
Journal:  Am J Pathol       Date:  1973-09       Impact factor: 4.307

10.  Autoantibodies and the hepatitis-associated antigen in acute infective hepatitis.

Authors:  L J Farrow; E J Holborow; G D Johnson; S G Lamb; J S Stewart; P E Taylor; A J Zuckerman
Journal:  Br Med J       Date:  1970-06-20
View more
  4 in total

1.  Precipitating antibodies to rabbit thymus extractable antigens in chronic liver disease: relationship with anti-actin antibodies.

Authors:  F Cassani; M Fusconi; F B Bianchi; L Selleri; L Baffoni; M Lenzi; E Pisi
Journal:  Clin Exp Immunol       Date:  1987-06       Impact factor: 4.330

2.  Liver cell membrane antibody detected by protein A and isolated rabbit liver plasma membrane in sera of patients with chronic liver diseases.

Authors:  G Toda; Y Ikeda; N Hashimoto; M Yamazaki; M Torii; H Oka
Journal:  Clin Exp Immunol       Date:  1983-12       Impact factor: 4.330

3.  Reaction against liver cells by human antiactin antibodies purified by affinity chromatography.

Authors:  K Riison; H Diederichsen; I Andersen
Journal:  J Clin Pathol       Date:  1982-07       Impact factor: 3.411

Review 4.  Thioredoxin-interacting protein (TXNIP) as a target for Alzheimer's disease: flavonoids and phenols.

Authors:  Meng Zhang; Guanhua Hu; Nan Shao; Yunpeng Qin; Qian Chen; Yan Wang; Peng Zhou; Biao Cai
Journal:  Inflammopharmacology       Date:  2021-08-04       Impact factor: 4.473

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.